The impact of antibiotic resistance on the rampant spread of infectious diseases in Pakistan: Insights from a narrative review

• Published in: Health science reports 2024-04, Vol.7 (4), p.e2050-n/a
• Main Authors: Mirha, Hania‐Tul, Ali, Syed H., Aamar, Humna, Sadiq, Mahnoor, Tharwani, Zoaib H., Habib, Zehra, Malikzai, Abdullah
• Format: Article
• Language: English
• Subjects: 19th century; antibiotic resistance; Antibiotics; Bacteria; Critical Care Medicine; Disease control; Drug Regulatory Authority of Pakistan; Drug resistance; Emergency Medicine; Epidemics; Epidemiology; General Medicine; Genetics and Genomics; Global Health; Immunology; Infections; Infectious Diseases; Microorganisms; Mortality; Narrative Review; Neurology; Paediatrics and Adolescent Medicine; Pakistan; Pandemics; Pathology and Laboratory Medicine; Penicillin; phage therapy; Public Health; Salmonella
• ISSN: 2398-8835; 2398-8835
• DOI: 10.1002/hsr2.2050

Background and Aims Antibiotic resistance (ABR) is a global public health emergency which has seen an uptick in low‐ to middle‐income countries in recent times due to a plethora of aggravating factors and has led to a whole host of setting‐specific pathogens registering high rates of resistance, causing outbreaks with graver mortality and morbidity. This review analyzes available literature to determine the causes and effects of ABR and recommend solutions to the problem in a Pakistani setting. Methods Sources for this narrative review were identified via electronic databases using keyword search methods. The information was retrieved using databases such as PubMed and Science Direct. Additionally, websites such as CDC and World Health Organization were used to attain pertinent information. All the sources were selected as per their relevance and appropriateness toward the purpose of this review. Results This review details the causes by dividing them into three primary strata, namely (1) under‐regulation, (2) over‐prescription and self‐medication, and (3) lack of medical stewardship. This is made much graver when the COVID‐19 pandemic and the subsequent erratic treatment response is considered, with the pandemic augmenting already high levels of consumption. These factors have led a cascade of effects including, but not limited to, a considerable increase in ABR in pathogens to first‐line drugs Conclusion ABR is a serious and growing issue which will result in undesirable personal, local, and national consequences if unchecked. Mitigation and reversal of this trend is necessary by developing existing programs and investing in novel therapies and pharmaceutical research and strengthening regulatory policies and mechanisms.